LIFEWARD LTD(NASDAQ:LFWD) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to LFWD. LFWD was compared to 189 industry peers in the Health Care Equipment & Supplies industry. While LFWD seems to be doing ok healthwise, there are quite some concerns on its profitability. LFWD is valued quite expensive, but it does show an excellent growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

LFWD had negative earnings in the past year.

In the past year LFWD has reported a negative cash flow from operations.

LFWD had negative earnings in each of the past 5 years.

In the past 5 years LFWD always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -94.93%, LFWD is not doing good in the industry: 80.95% of the companies in the same industry are doing better.

LFWD has a Return On Equity of -153.55%. This is in the lower half of the industry: LFWD underperforms 67.72% of its industry peers.

		Industry Rank	Sector Rank
ROA	-94.93%
ROE	-153.55%
ROIC	N/A

ROA(3y)-52.11%

ROA(5y)-43.2%

ROE(3y)-76.61%

ROE(5y)-60.74%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

LFWD has a worse Gross Margin (32.02%) than 73.02% of its industry peers.

In the last couple of years the Gross Margin of LFWD has declined.

The Profit Margin and Operating Margin are not available for LFWD so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	32.02%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-13.02%

GM growth 5Y-10.56%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

LFWD does not have a ROIC to compare to the WACC, probably because it is not profitable.

LFWD has more shares outstanding than it did 1 year ago.

LFWD has more shares outstanding than it did 5 years ago.

LFWD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -12.31, we must say that LFWD is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -12.31, LFWD is doing worse than 83.07% of the companies in the same industry.

There is no outstanding debt for LFWD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-12.31

ROIC/WACCN/A

WACC9.02%

2.3 Liquidity

A Current Ratio of 2.08 indicates that LFWD has no problem at all paying its short term obligations.

LFWD has a worse Current ratio (2.08) than 65.08% of its industry peers.

LFWD has a Quick Ratio of 1.43. This is a normal value and indicates that LFWD is financially healthy and should not expect problems in meeting its short term obligations.

LFWD has a Quick ratio of 1.43. This is in the lower half of the industry: LFWD underperforms 65.08% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.08
Quick Ratio	1.43

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

LFWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.94%, which is quite impressive.

Looking at the last year, LFWD shows a very strong growth in Revenue. The Revenue has grown by 85.24%.

The Revenue has been growing by 39.41% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)37.94%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%36.99%

Revenue 1Y (TTM)85.24%

Revenue growth 3Y62.63%

Revenue growth 5Y39.41%

Sales Q2Q%-4.79%

3.2 Future

Based on estimates for the next years, LFWD will show a very strong growth in Earnings Per Share. The EPS will grow by 22.43% on average per year.

The Revenue is expected to grow by 42.72% on average over the next years. This is a very strong growth

EPS Next Y52.94%

EPS Next 2Y33.84%

EPS Next 3Y25.41%

EPS Next 5Y22.43%

Revenue Next Year13.15%

Revenue Next 2Y31.32%

Revenue Next 3Y33.28%

Revenue Next 5Y42.72%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

LFWD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LFWD. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as LFWD's earnings are expected to grow with 25.41% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y33.84%

EPS Next 3Y25.41%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for LFWD!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

LIFEWARD LTD

NASDAQ:LFWD (5/21/2025, 8:12:38 PM)

After market: 1.1802 -0.01 (-0.82%)

1.19

-0.07 (-5.56%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)05-15 2025-05-15/bmo

Earnings (Next)08-13 2025-08-13

Inst Owners10.69%

Inst Owner ChangeN/A

Ins Owners2.63%

Ins Owner Change49.08%

Market Cap12.65M

Analysts82.22

Price Target8.84 (642.86%)

Short Float %3.86%

Short Ratio0.17

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-13.67%

Min EPS beat(2)-18.41%

Max EPS beat(2)-8.93%

EPS beat(4)1

Avg EPS beat(4)-4.68%

Min EPS beat(4)-18.41%

Max EPS beat(4)10.87%

EPS beat(8)2

Avg EPS beat(8)-7.48%

EPS beat(12)2

Avg EPS beat(12)-20.15%

EPS beat(16)3

Avg EPS beat(16)-19.58%

Revenue beat(2)0

Avg Revenue beat(2)-17.26%

Min Revenue beat(2)-28.9%

Max Revenue beat(2)-5.62%

Revenue beat(4)0

Avg Revenue beat(4)-10.59%

Min Revenue beat(4)-28.9%

Max Revenue beat(4)-1.18%

Revenue beat(8)1

Avg Revenue beat(8)-11.26%

Revenue beat(12)2

Avg Revenue beat(12)-19.3%

Revenue beat(16)5

Avg Revenue beat(16)-13.31%

PT rev (1m)-3.7%

PT rev (3m)-8.77%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-26.67%

EPS NY rev (1m)0%

EPS NY rev (3m)-12.78%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-23.56%

Revenue NY rev (1m)-0.86%

Revenue NY rev (3m)-22.73%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.49
P/FCF	N/A
P/OCF	N/A
P/B	0.67
P/tB	1.12
EV/EBITDA	N/A

EPS(TTM)-1.93

EYN/A

EPS(NY)-0.46

Fwd EYN/A

FCF(TTM)-2.04

FCFYN/A

OCF(TTM)-2.04

OCFYN/A

SpS2.41

BVpS1.77

TBVpS1.06

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-94.93%
ROE	-153.55%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	32.02%
FCFM	N/A

ROA(3y)-52.11%

ROA(5y)-43.2%

ROE(3y)-76.61%

ROE(5y)-60.74%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-13.02%

GM growth 5Y-10.56%

F-Score3

Asset Turnover0.84

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	0%
Cap/Sales	0%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.08
Quick Ratio	1.43
Altman-Z	-12.31

F-Score3

WACC9.02%

ROIC/WACCN/A

Cap/Depr(3y)5.59%

Cap/Depr(5y)12.01%

Cap/Sales(3y)0.35%

Cap/Sales(5y)0.7%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)37.94%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%36.99%

EPS Next Y52.94%

EPS Next 2Y33.84%

EPS Next 3Y25.41%

EPS Next 5Y22.43%

Revenue 1Y (TTM)85.24%

Revenue growth 3Y62.63%

Revenue growth 5Y39.41%

Sales Q2Q%-4.79%

Revenue Next Year13.15%

Revenue Next 2Y31.32%

Revenue Next 3Y33.28%

Revenue Next 5Y42.72%

EBIT growth 1Y17.19%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-4.68%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-5.09%

OCF growth 3YN/A

OCF growth 5YN/A

LIFEWARD LTD (LFWD) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens